melanotan 2 peptide pro Melanotan II (“Tan Jabs”): Why

It is the most common potentially fatal genetic disorder in the Caucasian population, affecting 1 in 2,4003,500 live births [1, 2]

In the EU, compliance with EC No 1272/2008 (CLP Regulation) and ISO 22716 is required

As with any research peptide, observations may vary depending on laboratory conditions, research models, and study objectives

The peptide originated in research on a naturally occurring ACTH fragment that has neurotrophic activity, meaning effects related to the growth and maintenance of nerve cells

Furthermore, non-specific protein adsorption, aptamer degradation, and electrode contamination in biological environments can limit long-term stability and signal reproducibility [157]